S18-000003

CAS : 2068119-11-7

Ref. 3D-THD11911

Informations sur le produit

• Nom: S18-000003

Description

Pro-inflammatory cytokines are a class of proteins that are integral to the immune response. The pro-inflammatory cytokine IL-17 is a crucial player in autoimmune disorders, as it promotes inflammation and protects against invading bacteria and fungi. IL-17 also has an important role in the development of cardiac disease, as it stimulates inflammation in heart tissue and can lead to cardiac damage. It is believed that the inhibition of IL-17 could provide new therapeutic strategies for autoimmune diseases and inflammatory diseases. S18-000003 is a synthetic drug that targets IL-17 production by binding to the retinoic acid receptor (RAR) beta, which is the target for retinoic acid synthesis. This drug has been shown to reduce the production of pro-inflammatory cytokines such as IL-17, providing a potential therapeutic strategy for autoimmune disorders and inflammatory diseases.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 518.5 g/mol
• Formule: C₂₆H₂₅F₃N₂O₄S
• Degré de pureté: Min. 95%